BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6840308)

  • 21. Efficacy of the symptothermal method of natural family planning in lactating women after the return of menses.
    Zinaman M; Stevenson W
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2037-9. PubMed ID: 1755465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mean versus individual hormonal profiles in the menstrual cycle.
    Alliende ME
    Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Natural family planning (symptothermal method) and objective ovulation parameters--a pilot study].
    Freundl G; Suberg D; Flynn AM; Diemer HP
    Geburtshilfe Frauenheilkd; 1984 Jun; 44(6):368-74. PubMed ID: 6378714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Lady Free Biotester in determining the fertile period.
    Fehring RJ; Gaska N
    Contraception; 1998 May; 57(5):325-8. PubMed ID: 9673839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The temporal relationship between vaginal fluid volumes obtained with the Rovumeter vaginal aspirator and the fertile phase of the cycle.
    Flynn AM; McCarthy AM; Docker M; Royston JP
    Hum Reprod; 1988 Feb; 3(2):201-5. PubMed ID: 3356775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal relation of ovulation to salivary and vaginal electrical resistance patterns: implications for natural family planning.
    Moreno JE; Weitzman GA; Doody MC; Gibbons WE; Besch P; Goldzieher JW
    Contraception; 1988 Oct; 38(4):407-18. PubMed ID: 3208515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural family planning: suitability of the CUE method for defining the time of ovulation.
    Moreno JE; Khan-Dawood FS; Goldzieher JW
    Contraception; 1997 Apr; 55(4):233-7. PubMed ID: 9179455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the BIOSELF 110 fertility indicator.
    Ismail M; Arshat H; Pulcrano J; Royston P; Spieler J
    Contraception; 1989 Jan; 39(1):53-71. PubMed ID: 2642781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of teaching cervical mucus symptoms to ovulating infertile women.
    Graham FM; Gosling L; France JT
    Aust N Z J Obstet Gynaecol; 1983 Nov; 23(4):226-30. PubMed ID: 6585197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An estrogen test to determine the times of potential fertility in women.
    Schiphorst LE; Collins WP; Royston JP
    Fertil Steril; 1985 Sep; 44(3):328-34. PubMed ID: 3896861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
    Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
    J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural family planning. New drug-free, device-free birth-control methods everybody's talking about.
    Aguilar N
    Fam Circle; 1978 Mar; ():T2. PubMed ID: 12339767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods of monitoring menstrual function in field studies: efficacy of methods.
    Kesner JS; Wright DM; Schrader SM; Chin NW; Krieg EF
    Reprod Toxicol; 1992; 6(5):385-400. PubMed ID: 1463919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
    Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
    Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
    Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The sympto-thermal methods].
    Parenteau-carreau S
    Contracept Fertil Sex (Paris); 1983 Nov; 11(11):1189-203. PubMed ID: 12312702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prototype for ovulation detection: pros and cons.
    Lasley BL; Shideler SE; Munro CJ
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2003-7. PubMed ID: 1755459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-palpation to assess cervical changes in relation to mucus and temperature.
    Parenteau-Carreau S; Infante-Rivard C
    Int J Fertil; 1988; 33 Suppl():10-6. PubMed ID: 2902020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.